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Variant in the X-chromosome spliceosomal gene
GPKOW causes male-lethal microcephaly with
intrauterine growth restriction
Renée Carroll1,2,7, Raman Kumar1,2,7, Marie Shaw1,2, Jennie Slee3, Vera M Kalscheuer4, Mark A Corbett1,2 and
Jozef Gecz*,1,2,5,6
Congenital microcephaly, with or without additional developmental defects, is a heterogeneous disorder resulting from impaired
brain development during early fetal life. The majority of causative genetic variants identified thus far are inherited in an
autosomal recessive manner and impact key cellular pathways such as mitosis, DNA damage response and repair, apoptosis and
splicing. Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (GPKOW) gene
(NG_021310.2:g.6126G4A, NM_015698.4:c.331+5G4A) that segregates with affected and carrier status in a
multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth
restriction (IUGR). GPKOW is a core member of the spliceosome that has been shown in numerous model organisms and in
human cells to be essential for survival. By investigating GPKOW transcripts in lymphoblastoid cell lines (LCLs) of three carrier
females, we show that the GPKOW c.331+5G4A variant disrupts normal splicing of its pre-mRNAs. In a clonal culture
expressing only the c.331+5G4A allele isolated from one carrier female LCL, we observed an 80% reduction in wild type
GPKOW mRNA, 70% reduction in the full length GPKOW protein and the presence of a truncated GPKOW protein with possible
dominant negative effect. Based on our and published data we propose that the GPKOW gene is essential for fetal development
and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR.
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INTRODUCTION
Congenital microcephaly, a condition where head circumference at
birth is significantly below the mean for age and sex, is the result of
impaired brain development during early fetal life.1 While the genetic
causes are diverse, causative variants predominantly show an auto-
somal recessive mode of inheritance and affect fundamental cellular
pathways such as the assembly and function of the mitotic apparatus;
DNA replication, damage and repair; apoptosis signaling and mRNA
splicing.1,2 Why the developing fetal brain is particularly sensitive to
even subtle alterations in pathways core to all living cells is still being
investigated.2,3
We studied a previously reported multigenerational family with a
male lethal condition primarily characterized by severe microcephaly
with IUGR and variable presentation of additional developmental
defects,4 with carrier females possibly presenting with a mild
phenotype. We identified a rare variant in a canonical donor splice
site of the X-linked splicing factor gene GPKOW as the most likely
cause of this condition.
MATERIALS AND METHODS
Details of materials and methods can be found in the Supplementary
Information.
RESULTS
X-exome sequencing of obligate carrier III-2 (Figure 1a) and
subsequent variant filtering identified five novel heterozygous variants
(Supplementary Table 1), of which the GPKOW (NG_021310.2:
g.6126G4A; NM_015698.4:c.331+5G4A) and IRS4 (NG_013239.1:
g.7189C4T; NM_003604.2:c.2156C4T) variants were considered
candidates. However, only the GPKOW c.331+5G4A splice-site
variant segregated in nine additional family members, including one
affected male fetus (Figure 1a and Supplementary Table 3). The
GPKOW c.331+5G4A did not have a damaging CADD score5
(Supplementary Table 1), however different in silico prediction tools
calculated a decrease in splicing efficiency as compared to wild type
sequence (Supplementary Table 2). GPKOW has a probability of
loss-of-function intolerance Z score of 0.98 in ExAC,6 suggesting
that disruption of this gene is likely to be damaging (Supplementary
Table 1).
Extreme skewing (4 90%) of X chromosome inactivation (XCI)
was observed in blood-derived genomic DNA from three females; II-8,
III-2 and III-4 (Figure 1a), however skewing of XCI ratios did not
co-segregate with obligate carrier status or presence of the GPKOW
variant. Namely, I-2 and II-2 are obligate carriers and heterozygous for
GPKOW c.331+5G4A variant yet have random XCI, whereas III-4,
who has not conceived affected children and is homozygous wild type
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(WT) at this locus, has skewed XCI to the ratio of 97:3. Furthermore,
skewed XCI, as assessed on venous blood DNA, does not appear to be
fully protective against the effect of the GPKOW variant in carrier
females. For example, II-8 has highly skewed XCI yet her height and
occipitofrontal circumference (OFC) measurements are in the o1st
and 2nd centiles, respectively. Incidentally, we observed a missense
variant in exon 1 of the AR gene (NG_009014.2:g.6285T4A,
NM_000044.3:c.170T4A, p.(Leu57Gln), rs78686797) that is in link-
age disequilibrium with the GPKOW c.331+5G4A variant
(Supplementary Figure 1c). This was supported by determining the
AR allele inheritance for affected and unaffected male family members
(Supplementary Table 3). Subsequently, we used the methylation
status of the AR sequence tagged site (NCBI Probe database
Pr012386469) that flanks rs78686797 as a proxy to indicate WT or
variant GPKOW allele expression. LCLs from carrier females I-2, II-2
and III-2 were all highly skewed toward expression of the WT
GPKOW allele (Supplementary Figure 3). XCI measured on DNA
from LCLs differed to XCI measured from venous blood DNA for
obligate carriers I-2 and II-2 (see Supplementary Figure 3A).
Given the severity of the disorder we did not have access to a viable
cell source from an affected male. To investigate whether the GPKOW
c.331+5G4A donor splice site variant alters GPKOW pre-mRNA
splicing and creates alternative mRNA species harboring premature
termination codons (PTC) that are subject to Nonsense Mediated mRNA
Decay (NMD), we inhibited NMD in low passage LCLs from three
carrier (I-2, II-2 and III-2) and three control females with cycloheximide
(CHX). Increased levels of bona fide NMD target GADD45B
mRNA confirmed NMD inhibition (Supplementary Figure 2).
Figure 1 (a) Family pedigree. Genotyped individuals are indicated as WT +/Y or +/+; carrier − /+; affected -/Y. XCI ratios (peripheral blood DNA) for the tested
females are shown (Supplementary Table 3). Foetus II-6 was a missed miscarriage at 25/40, III-3 died in the neonatal period at 36/40, III-5 was stillborn at
34/40, and pregnancies III-7 and IV-1 were terminated at 21/40 and 18.5/40, respectively, following diagnosis by ultrasound. IUGR, intrauterine growth
restriction. (b) Schematic structure of GPKOW gene and protein. Arrow indicates location of +5G4A variant in the donor splice site of exon 2. One G-Patch
domain, two KOW motifs and a predicted nuclear localisation sequence (NLS, aa 331–334) are shown. Exons are numbered as in NCBI Refseq
NG_021310.2 and the amino acid locations of different domains are from the NCBI Refseq NP_056513.2. The shaded box indicates the aa 59–189
missing from the truncated protein, based on transcript D cDNA sequence. (c) Schematic representation of the four different transcripts identified in the
cycloheximide (CHX) assay. Asterisks represent premature termination codons (PTC) introduced due to shifts in reading frame. (d) c.331+5G4A carrier
female LCLs show additional aberrant processing of GPKOW pre-mRNA. Agarose gel showing GPKOW transcripts amplified from carrier and control female
LCLs cultured in the presence (+) or absence (–) of CHX. Full-length (WT) and aberrantly-spliced (A–D) transcripts are indicated by arrows. XCI ratios assayed
from LCL gDNA from three carrier females are also shown.
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RT-PCR amplification of GPKOW mRNA using primers located
within exons 1 and 5 revealed four aberrant GPKOW transcripts in
addition to the full-length transcript (Figures 1b-d). Transcripts A and
B were present in all CHX-treated LCLs suggesting they result from
normal splicing events unrelated to the c.331+5G4A variant, and as
they were largely undetectable in the untreated LCLs, are naturally
degraded by NMD. Sanger sequencing revealed transcript A lacks exon
3 and transcript B lacks exons 3 and 4 (Figures 1c and d and
Supplementary Figure 1b), in both cases causing frameshifts and the
introduction of a PTC. Transcripts C and D were only amplified from
carrier female samples, suggesting they result from incorrect proces-
sing of the allele with the variant c.331+5G4A donor splice site.
Transcript C was predominantly detected in the CHX-treated samples
indicating it is subject to NMD. Sanger sequencing revealed transcript
C lacks exons 2 and 3, causing frameshift and the introduction of a
PTC. Presence of comparable levels of transcript D in CHX-treated
and untreated carrier female LCLs suggested that it is refractory to
NMD. Sanger sequencing showed that transcript D lacks exons 2, 3
and 4, maintaining the reading frame (Figures 1c and d and
Supplementary Figure 1b). The differences in the abundance of
transcripts C and D observed between the carrier female LCLs
(Figure 1d) corresponded to the percentage of the cells in each
culture expressing the GPKOW c.331+5G4A allele, as determined by
methylation status of the AR c.170T4A, p.(Leu57Gln) allele.
To further investigate the c.331+5G4A variant in isolation from
sequence-confirmed WT allele expression, we isolated clonal cultures
from the LCL of carrier female II-2. From 13 successfully isolated
clones, 12 expressed the WT GPKOW allele and one the c.331+5G4A
variant allele (Supplementary Figure 3b). Real time quantitative PCR
(RT-qPCR) revealed that full length GPKOW levels were reduced by
80% in the c.331+5G4A expressing clone as compared to three
independent WT expressing clones and three unrelated controls
(Figure 2a). Western blot analysis showed a corresponding 70%
reduction in full-length GPKOW protein, with the presence of an
additional band at approximately 40 kDa, corresponding to the size
predicted for transcript D translation product (Figures 2b and c).
Indirect immunofluorescent detection of GPKOW protein in clonal
LCL cultures demonstrated significant reduction in GPKOW levels but
no discernible effect on its localization in the c.331+5G4A variant
cells compared to WT cells and unrelated controls (Figure 3).
DISCUSSION
That RNA metabolism is fundamental to normal brain development
and neuronal function is demonstrated by the complexity of alter-
native precursor messenger RNA (pre-mRNA) splicing in the human
brain.7 In excess of 350 disorders, including many neurodevelop-
mental disorders, are consequences of genetic variants affecting pre-
mRNA splicing.8 Furthermore, variants in splicing factors themselves
are reported to cause a wide variety of human diseases.8–10
In this work we implicate GPKOW in a male-lethal developmental
disorder. GPKOW is a ubiquitously expressed nuclear RNA-binding
protein that has been identified as a core member of the
spliceosome.11 GPKOW associates with catalytically active complexes
Bact and C11,12 and acts as an essential cofactor for the two DEAH-box
helicases, DHX16 and DHX38, which sequentially catalyze the key
transesterification reactions. GPKOW has been classified as essential
for human cell survival,13 and there are no known paralogs in the
human genome. Moreover, there are no homozygous or hemizygous
loss of function variants thus far listed in ExAC.6 However, DECI-
PHER lists a patient (#286121) with a 1.4 Mbp deletion including the
GPKOW gene and a 33Mbp pathogenic deletion of chromosome 21,
presenting microcephaly as one of the clinical symptoms. GPKOW is
highly conserved and has been shown to be essential for life in
numerous model organisms. For example, in Caenorhabditis elegans,
RNAi manipulation of its GPKOW ortholog R11A8.2 results in
embryonic lethality in more than 80% of cases and the minority that
survived had morphological growth defects.14 RNAi silencing of the
GPKOW ortholog CG10324 in Drosophila melanogaster neuroblasts is
early lethal and causes under proliferation.15 To our knowledge, no
vertebrate model of a GPKOW knockout has been generated.
The GPKOW c.331+5G4A variant we identified was predicted in
silico to adversely impact spliceosomal processing of exon 2 donor
splice site (Supplementary Table 2). Although adenine at the +5
position occurs in approximately 9% of human donor splice sites
genome-wide,16 there are numerous reported cases of +5G4A
disease-associated variants causing aberrant pre-mRNA processing.17
Blocking NMD in LCLs from three carrier females revealed the
expression of the c.331+5G4A allele is correlated with the production
of aberrant transcripts C and D. Current evidence shows that GPKOW
is subject to XCI18 and as such in a female the gene is expressed only
from the active X-chromosome. Using clonal WT and c.331+5G4A
Figure 2 GPKOW full length WT mRNA and protein are significantly reduced in the c.331+5G4A LCL clone (MT). (a) Graph showing GPKOW mRNA levels
relative to ACTB. RT-qPCR data from independent WT clones (n=3), c.331+5G4A clones (n=2; different passages of the same culture) from the carrier
female II-2, and normal controls (n=3) was averaged and error bars show SD. (b) Western blot showing full length GPKOW from independent WT clones
(n=3), the c.331+5G4A clone (n=2; different passages of the same culture; P1, P2), and normal controls (n=3). An additional band at around 40kDa in
the c.331+5G4A (MT) clones P1 and P2 corresponds to the predicted size of a truncated protein translated from transcript D. (c) Graph showing the mean
densitometry values of full length GPKOW protein relative to β-actin. Western blot signals in (b) were measured by ImageJ software and normalised to
housekeeping β-actin protein. Error bars show SD.
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variant expressing LCL cultures from one carrier female we show the
likely effect of the c.331+5G4A variant on GPKOW mRNA splicing.
In the c.331+5G4A allele-expressing LCL clone, we observed full-
length transcript levels were reduced by 80% as compared to
expression levels in WT-expressing cultures (Figure 2a). Importantly,
we also observed a corresponding 70% reduction in full-length
GPKOW protein, and the presence of a truncated GPKOW protein,
corresponding to the transcript D translation product (Figures 2b and c).
The truncated protein is predicted to lack amino acids 59–189
(Figures 1b and c), spanning the first two-thirds of the G-patch
domain, which has been shown to be important for GPKOW binding
to DHX16.12 Consequently, we predict that the truncated protein,
even if folded and localized correctly, would be unlikely to function
properly as a cofactor in spliceosomal reactions. We also speculate that
the truncated GPKOW protein may have a dominant negative effect
by competing with residual WT GPKOW for binding sites and/or
binding to and sequestering other spliceosomal factors.
Testing of X-chromosome inactivation provided conflicting data.
Three females (II-8, III-2 and III-4) of whom two are obligate carriers
(II-8 and III-2), had highly skewed XCI, while two other obligate
carriers (I-2 and II-2) showed random XCI. However, when we tested
XCI on DNA isolated from LCLs of three obligate carriers, two of
whom have variable XCI in blood (I-2 and II-2), we found all three to
have highly skewed XCI favoring expression of the wild type GPKOW
allele (Supplementary Figure 3a). Skewing of XCI also doesn’t appear
to be protective of the possible mild phenotype observed in the
obligate carrier females (Supplementary Table 3). On aggregate, the
combined data on XCI in blood and LCL DNA and on multiple
obligate carrier and wild type females in this family show a complex,
yet to be resolved mechanism of XCI skewing in different tissues. It
also appears that a factor unrelated to the GPKOW variant and
involved in high XCI skewing, might also be segregating in this family
(e.g. wild type female III-4 with high skewing of XCI; Figure 1a).
How significantly reduced levels of WT GPKOW along with any
function of the truncated GPKOW lead to the observed male-lethal
phenotype remains to be determined. However, there are a number of
severe congenital disorders with the shared features of microcephaly
and growth retardation that are attributed to genetic variants in
splicing factors. For example, mandibulofacial dysostosis, Guion-
Almeida type (MFDGA, OMIM #610536) is caused by heterozygous
variants in EFTUD2; Verheij syndrome (OMIM #615583) has recently
been attributed to heterozygous variants in PUF60;19 and microce-
phalic osteodysplastic primordial dwarfism type I (MOPD1, OMIM
#210710) caused by recessive variants in RNU4ATAC. Furthermore,
the particular sensitivity of males to mutations in X-linked splicing
factors is demonstrated with the example TARP syndrome (OMIM
#311900), a male-lethal developmental disorder caused by mutations
in the X-linked gene RNA Binding Motif Protein 10 (RBM10).20
Our findings show that a variant in the X-chromosome essential
splicing factor GPKOW is the likely cause of a male-lethal disorder
featuring microcephaly and IUGR, and add to the growing number
spliceosomal gene variants implicated in severe developmental dis-
orders, highlighting the crucial role of pre-mRNA splicing in human
development.8 Further investigations to elucidate the role of GPKOW
in normal development are warranted.
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